- Home
- KDP vs WGSWW Comparison
KDP vs WGSWW Comparison
Compare KDP & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KDP
- WGSWW
- Stock Information
- Founded
- KDP 1981
- WGSWW 2017
- Country
- KDP United States
- WGSWW United States
- Employees
- KDP N/A
- WGSWW 1000
- Industry
- KDP Beverages (Production/Distribution)
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- KDP Consumer Staples
- WGSWW Technology
- Exchange
- KDP Nasdaq
- WGSWW Nasdaq
- Market Cap
- KDP N/A
- WGSWW N/A
- IPO Year
- KDP 1993
- WGSWW N/A
- Fundamental
- Price
- KDP $32.72
- WGSWW $0.05
- Analyst Decision
- KDP Strong Buy
- WGSWW
- Analyst Count
- KDP 15
- WGSWW 0
- Target Price
- KDP $39.33
- WGSWW N/A
- AVG Volume (30 Days)
- KDP 15.0M
- WGSWW 36.6K
- Earning Date
- KDP 04-24-2025
- WGSWW 02-18-2025
- Dividend Yield
- KDP 2.81%
- WGSWW N/A
- EPS Growth
- KDP N/A
- WGSWW N/A
- EPS
- KDP 1.10
- WGSWW N/A
- Revenue
- KDP $15,518,000,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- KDP $6.44
- WGSWW N/A
- Revenue Next Year
- KDP $3.98
- WGSWW N/A
- P/E Ratio
- KDP $29.76
- WGSWW N/A
- Revenue Growth
- KDP 3.94
- WGSWW 50.79
- 52 Week Low
- KDP $30.12
- WGSWW $0.17
- 52 Week High
- KDP $38.28
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- KDP 33.79
- WGSWW N/A
- Support Level
- KDP $33.82
- WGSWW N/A
- Resistance Level
- KDP $34.42
- WGSWW N/A
- Average True Range (ATR)
- KDP 0.59
- WGSWW 0.00
- MACD
- KDP -0.21
- WGSWW 0.00
- Stochastic Oscillator
- KDP 12.63
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.